Results 101 to 110 of about 4,073,186 (254)
Background: The metabolic syndrome is a global health problem and is associated with subsequent development of cardiovascular disease (CVD). However, data are scarce concerning prospective association of the syndrome and CVD in populations free of ...
Bergström, Göran,, Schmidt, Caroline,
core +1 more source
Bridging the translational gap in clinical nanomedicine: From rational design to clinical reality
Nanotechnology offers a multi‐faceted approach to modern healthcare, encompassing high‐sensitivity diagnostic imaging, innovative vaccine delivery, and targeted therapeutics. This review explores how these nanomedicine applications address critical challenges in cancer recurrence and the treatment of neurologic and respiratory diseases to combat rising
Ahmed H. Ghonaim +9 more
wiley +1 more source
Background The Cardiovascular-Kidney-Metabolic (CKM) syndrome framework acknowledges metabolic dysfunction-associated steatotic liver disease (MASLD) as a major manifestation, yet hepatic involvement remains insufficiently incorporated into risk ...
Yan Guo +3 more
doaj +1 more source
Kaplan–Meier hypertension‐free survival by baseline body mass index category, primary adult cohort (men aged ≥ 18 years, n = 12,742). Time since baseline in years is plotted on the horizontal axis and the probability of remaining free of treated hypertension is plotted on the vertical axis. Numbers at risk are shown beneath the plot.
Ebenezer Afrifa‐Yamoah
wiley +1 more source
The identification of pathological links among metabolic disorders, kidney ailments, and cardiovascular conditions has given rise to the concept of cardiovascular–kidney–metabolic (CKM) syndrome.
Chien-Ning Hsu, You-Lin Tain
core +1 more source
Cholesterol Goal Attainment in Hypertensive Patients: the Impact of Metabolic Syndrome Components
Background: Hypertension and dyslipidemia are potentially modifiable cardiovascular risk factors.Methods: We studied hypertensive outpatients regarding goal attainment in controlling dyslipidemia, according to individual cardiovascular risk profile ...
Batista, Marcelo Costa +4 more
core +1 more source
Clinical significance of acute kidney injury in idiosyncratic drug‐induced liver injury: a multicentric propensity scores matched study. Evidence about the role of acute kidney injury (AKI) in idiosyncratic drug‐induced liver injury (DILI) is still scarce.
José María Pinazo‐Bandera +15 more
wiley +1 more source
Background Cardiovascular-kidney-metabolic (CKM) syndrome reflects the interplay of metabolic dysfunction, chronic kidney disease (CKD), and cardiovascular disease (CVD).
Yumeng Liu, Zhongguang Yang, Yulin Yin
doaj +1 more source
Association between vascular aging and cardiovascular-kidney-metabolic syndrome [PDF]
BackgroundThe concept of Cardiovascular-Kidney-Metabolic syndrome (CKM), an intricate interplay among metabolic risk factors, chronic kidney disease (CKD), and the cardiovascular system, was introduced by the American Heart Association (AHA).
Lei Chen +7 more
core +1 more source
Pain is a key determinant of quality‐of‐life following breast cancer surgery, the most common cancer operation in the United States. Gabapentinoids are frequently prescribed for pain management, yet their respiratory, cardiovascular, and opioid‐related adverse effects remain unclear.
Jyun‐Heng Lai +12 more
wiley +1 more source

